0001209191-20-018991.txt : 20200313
0001209191-20-018991.hdr.sgml : 20200313
20200313172903
ACCESSION NUMBER: 0001209191-20-018991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murray Christine
CENTRAL INDEX KEY: 0001600361
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 20714131
MAIL ADDRESS:
STREET 1: C/O ACHAOGEN, INC.
STREET 2: 7000 SHORELINE COURT, SUITE 371
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-12
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001600361
Murray Christine
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
1
0
0
0
Common Stock
2020-03-12
4
A
0
5000
0.00
A
5000
D
Stock Option (Right to Buy)
5.60
2020-03-12
4
A
0
10000
0.00
A
2030-03-11
Common Stock
10000
10000
D
Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020.
The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.
/s/ Sriram Ryali, Attorney-in-Fact
2020-03-13